INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation - DDD — Neutral
DDD Accesswire — March 28, 2025NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation ("3D Systems" or the "Company") (NYSE:DDD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

ROSEN, LEADING INVESTOR COUNSEL, Encourages SoundHound AI, Inc. Investors to Inquire About Securities Class Action Investigation - SOUN, SOUNW — Neutral
SOUN Accesswire — March 28, 2025NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / WHY: New York, N.Y., March 28, 2025.

TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX — Neutral
TMDX Accesswire — March 28, 2025NEW YORK, NY / ACCESS Newswire / March 28, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=139547&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Shareholders of Monolithic Power Systems Inc. (MPWR) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
MPWR Accesswire — March 28, 2025NEW YORK, NY / ACCESS Newswire / March 28, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=139545&wire=1 or contact Joseph E. Levi, Esq.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATNM — Neutral
ATNM Accesswire — March 28, 2025NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE:ATNM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Investors who Lost Money on Quantum Computing Inc. (QUBT) Should Contact Levi & Korsinsky About Pending Class Action - QUBT — Neutral
QUBT Accesswire — March 28, 2025NEW YORK, NY / ACCESS Newswire / March 28, 2025 / If you suffered a loss on your Quantum Computing Inc. (NASDAQ:QUBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/quantum-computing-inc-lawsuit-submission-form?prid=139543&wire=1 or contact Joseph E. Levi, Esq.

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference — Neutral
TMCI GlobeNewsWire — March 28, 2025PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty ® and Adductoplasty ® Procedures, today announced the presentation of updated interim data for the ALIGN3D™ and Mini3D™ Lapiplasty® clinical studies, as well as the first presentation of the MTA3D™ Adductoplasty® clinical study, at the 2025 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting in Phoenix, Arizona.

Class Action Filed Against GSK plc (GSK) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
GSK Accesswire — March 28, 2025NEW YORK, NY / ACCESS Newswire / March 28, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=139546&wire=1 or contact Joseph E. Levi, Esq.

Semtech Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 22, 2025 to Discuss Your Rights - SMTC — Neutral
SMTC Accesswire — March 28, 2025NEW YORK, NY / ACCESS Newswire / March 28, 2025 / If you suffered a loss on your Semtech Corporation (NASDAQ:SMTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semtech-corporation-lawsuit-submission-form?prid=139544&wire=1 or contact Joseph E. Levi, Esq.

Amazon MGM Studios boss Jen Salke to step down. Read the internal memo — Negative
AMZN CNBC — March 28, 2025Jen Salke, the head of Amazon MGM Studios, is stepping down. Amazon hired Salke in 2018 to oversee its movie and television unit, and under her leadership, the company became a bigger player in the entertainment industry.

UnitedHealth Group Announcement: UNH Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH — Neutral
UNH GlobeNewsWire — March 28, 2025NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices.

As market uncertainty and volatility increase, investor sentiment is shifting. Defensive and value-oriented sectors are beginning to outperform, while high-growth areas, particularly technology, semiconductors, and AI—have come under pressure.

Compelling Reasons to Hold on to MarketAxess Stock Right Now — Positive
MKTX Zacks Investment Research — March 28, 2025MKTX remains well-poised for growth on the back of improved trading volumes, a well-established Open Trading platform and sufficient cash generation abilities.

enCore Energy (EU) Faces Securities Class Action As Investors Scrutinize Financial Reporting and Leadership Shakeup – Hagens Berman — Neutral
EU GlobeNewsWire — March 28, 2025SAN FRANCISCO, March 28, 2025 (GLOBE NEWSWIRE) -- A securities class action has been filed against enCore Energy Corp. (NASDAQ: EU), a uranium extraction company positioning itself as "America's Clean Energy Company," which saw its stock plummet 46% on Mar. 3, 2025, following a series of troubling disclosures. The suit, captioned Zhongjian v.

Rich Steinmeier doesn't want to think of LPL Financial LPLA-0.59% as just an independent broker-dealer. Now six months into his stint as LPL's CEO, Steinmeier says his firm wants to compete with the likes of Morgan Stanley MS-3.24%, Merrill Lynch, and Charles Schwab.

Teradata, Rapid7, and More Stocks See Action From Activist Investors — Positive
RPD TDC Market Watch — March 28, 2025These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.

Shares of Lululemon Athletica (LULU -14.81%) plunged on Friday, falling 14.3% as of 11:45 a.m. ET.

Simon Announces Opening of Jakarta Premium Outlets in Indonesia — Neutral
SPG Zacks Investment Research — March 28, 2025SPG's opening of the Jakarta Premium Outlets in Indonesia is expected to drive more traffic to this retail destination.

Microchip Technology's Fall From Grace: Can It Rebound? — Negative
MCHP Seeking Alpha — March 28, 2025Microchip Technology faces significant challenges, including a 50% revenue drop, declining margins, and high debt levels, making current investment unattractive. The company's heavy reliance on the Asian market and lack of long-term distributor agreements add to its financial instability and market uncertainty. The sustainability of Microchip's dividend is questionable, with free cash flow insufficient to cover payouts, suggesting a potential cut.

Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript — Neutral
HUMA Seeking Alpha — March 28, 2025Humacyte, Inc. (NASDAQ:HUMA ) Q4 2024 Earnings Conference Call March 27, 2025 8:30 AM ET Company Participants Thomas Johnson - Director, Corporate Communications, LifeSci Advisors, IR Laura Niklason - President and CEO Dale Sander - CFO and Chief Corporate Development Officer Conference Call Participants Josh Jennings - TD Cowen & Company Ryan Zimmerman - BTIG Vernon Bernardino - H.C. Wainwright Bruce Jackson - Benchmark Company Operator Good morning, ladies and gentlemen.
